Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease.

Carrat F, Seksik P, Colombel JF, Peyrin-Biroulet L, Beaugerie L; CESAME Study Group.

Aliment Pharmacol Ther. 2017 Feb;45(4):533-541. doi: 10.1111/apt.13897. Epub 2016 Dec 19.

PMID:
27995656
2.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group.

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9.

3.

Vaccination coverage of children with inflammatory bowel disease after an awareness campaign on the risk of infection.

Fleurier A, Pelatan C, Willot S, Ginies JL, Breton E, Bridoux L, Segura JF, Chaillou E, Jobert A, Darviot E, Cagnard B, Delaperriere N, Grimal I, Carre E, Wagner AC, Sylvestre E, Dabadie A.

Dig Liver Dis. 2015 Jun;47(6):460-4. doi: 10.1016/j.dld.2015.02.009. Epub 2015 Feb 26.

PMID:
25770456
4.

[Knowledge of adolescents with inflammatory bowel disease: Results of a multicenter cross-sectional survey].

Maignant S, Pélatan C, Breton E, Cagnard B, Chaillou E, Giniès JL, Le Hénaff G, Ségura JF, Willot S, Bridoux L, Jobert A, Darviot E, Delaperrière N, Lapeyre D, Carré E, Grimal I, Hankard R, Wagner AC, Balençon M, Caldari D, Tourtelier Y, Dabadie A.

Arch Pediatr. 2015 May;22(5):468-75. doi: 10.1016/j.arcped.2015.01.013. Epub 2015 Feb 26. French.

PMID:
25725972
5.

[Congenital portosystemic shunts: experience of the western region of France over 5 years].

Hubert G, Giniès JL, Dabadie A, Tourtelier Y, Willot S, Pariente D, Lefrançois T, Caldari D.

Arch Pediatr. 2014 Nov;21(11):1187-94. doi: 10.1016/j.arcped.2014.08.033. Epub 2014 Oct 2. Review. French.

PMID:
25282460
6.

Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results.

Bradley JM, Koker P, Deng Q, Moroni-Zentgraf P, Ratjen F, Geller DE, Elborn JS; Tiotropium Cystic Fibrosis Study Group.

PLoS One. 2014 Sep 4;9(9):e106195. doi: 10.1371/journal.pone.0106195. eCollection 2014.

7.

Predictors of response to infliximab in paediatric perianal Crohn's disease.

Dupont-Lucas C, Dabadie A, Alberti C, Ruemmele FM; GETAID (Group d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif) Pédiatrique.

Aliment Pharmacol Ther. 2014 Oct;40(8):917-29. doi: 10.1111/apt.12928. Epub 2014 Aug 22.

8.

Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective study.

Munck A, Kheniche A, Alberti C, Hubert D, Martine RG, Nove-Josserand R, Pin I, Bremont F, Chiron R, Couderc L, Dalphin ML, Darviot E, Delaisi B, Dominique S, Durieu I, Fanton A, Fayon M, Gérardin M, Giniès JL, Giraut C, Grenet D, Guillot M, Huet F, Le Bourgeois M, Murris-Epin M, Ramel S, Sardet A, Sermet-Gaudelus I, Varaigne F, Wanin S, Weiss L, Hurtaud MF.

J Cyst Fibros. 2015 Jan;14(1):97-103. doi: 10.1016/j.jcf.2014.05.015. Epub 2014 Aug 5.

9.

Immunization status in children with inflammatory bowel disease.

Longuet R, Willot S, Giniès JL, Pélatan C, Breton E, Segura JF, Bridoux L, Le Henaff G, Cagnard B, Jobert A, Cardonna J, Grimal I, Balençon M, Darviot E, Delaperrière N, Caldari D, Piloquet H, Dabadie A.

Eur J Pediatr. 2014 May;173(5):603-8. doi: 10.1007/s00431-013-2207-0. Epub 2013 Dec 5.

PMID:
24305728
10.

[Aquagenic palmoplantar keratoderma in children with cystic fibrosis].

Weil B, Chaillou E, Troussier F, Pelatan C, Chiffoleau M, Darviot E, Chevalier MC, Martin L, Giniès JL.

Arch Pediatr. 2013 Dec;20(12):1306-9. doi: 10.1016/j.arcped.2013.09.023. Epub 2013 Nov 5. French.

PMID:
24210985
11.

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L; CESAME Study Group.

Gut. 2014 Sep;63(9):1416-23. doi: 10.1136/gutjnl-2013-305763. Epub 2013 Oct 25.

PMID:
24162591
12.

[Hypomagnesemia after liver transplantation in children].

Nicaise D, Chaillou E, Willot S, Bridoux L, Cardona J, Jobert A, Pelatan C, Giniès JL.

Arch Pediatr. 2013 Aug;20(8):903-4. doi: 10.1016/j.arcped.2013.05.019. Epub 2013 Jul 1. French. No abstract available.

PMID:
23827375
13.

Proteolytic cleavage of the long pentraxin PTX3 in the airways of cystic fibrosis patients.

Hamon Y, Jaillon S, Person C, Giniès JL, Garo E, Bottazzi B, Ghamrawi S, Urban T, Subra JF, Bouchara JP, Mantovani A, Jeannin P, Delneste Y.

Innate Immun. 2013 Dec;19(6):611-22. doi: 10.1177/1753425913476741. Epub 2013 Mar 8.

PMID:
23475792
14.

CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders.

Thauvin-Robinet C, Munck A, Huet F, de Becdelièvre A, Jimenez C, Lalau G, Gautier E, Rollet J, Flori J, Nové-Josserand R, Soufir JC, Haloun A, Hubert D, Houssin E, Bellis G, Rault G, David A, Janny L, Chiron R, Rives N, Hairion D, Collignon P, Valeri A, Karsenty G, Rossi A, Audrézet MP, Férec C, Leclerc J, Georges Md, Claustres M, Bienvenu T, Gérard B, Boisseau P, Cabet-Bey F, Cheillan D, Feldmann D, Clavel C, Bieth E, Iron A, Simon-Bouy B, Izard V, Steffann J, Viville S, Costa C, Drouineaud V, Fauque P, Binquet C, Bonithon-Kopp C, Morris MA, Faivre L, Goossens M, Roussey M, Girodon E; collaborating working group on p.Arg117His.

J Med Genet. 2013 Apr;50(4):220-7. doi: 10.1136/jmedgenet-2012-101427. Epub 2013 Feb 1.

PMID:
23378603
15.

[Antineutrophil cytoplasmic autoantibodies in children: clinical features].

Allard L, Giniès JL, Champion G, Chevailler A, Subra JF.

Arch Pediatr. 2013 Mar;20(3):232-40. doi: 10.1016/j.arcped.2012.12.020. Epub 2013 Jan 30. French.

PMID:
23375711
16.

[Neonatal diarrhea due to congenital glucose-galactose malabsorption: report of seven cases].

Chedane-Girault C, Dabadie A, Maurage C, Piloquet H, Chailloux E, Colin E, Pelatan C, Giniès JL.

Arch Pediatr. 2012 Dec;19(12):1289-92. doi: 10.1016/j.arcped.2012.09.005. Epub 2012 Oct 26. French.

PMID:
23107089
17.

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis.

Boëlle PY, Viviani L, Busson PF, Olesen HV, Ravilly S, Stern M, Assael BM, Barreto C, Drevinek P, Thomas M, Krivec U, Mei-Zahav M, Vibert JF, Clement A, Mehta A, Corvol H; French CF Modifier Gene Study Investigators; European CF Registry Working Group.

Orphanet J Rare Dis. 2012 Sep 7;7:64. doi: 10.1186/1750-1172-7-64.

18.

AGER -429T/C is associated with an increased lung disease severity in cystic fibrosis.

Beucher J, Boëlle PY, Busson PF, Muselet-Charlier C, Clement A, Corvol H; French C F Modifier Gene Study Investigators.

PLoS One. 2012;7(7):e41913. Epub 2012 Jul 30.

19.

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

Sokol H, Beaugerie L, Maynadié M, Laharie D, Dupas JL, Flourié B, Lerebours E, Peyrin-Biroulet L, Allez M, Simon T, Carrat F, Brousse N; CESAME Study Group.

Inflamm Bowel Dis. 2012 Nov;18(11):2063-71. doi: 10.1002/ibd.22889. Epub 2012 Jan 23.

PMID:
22271569
20.

[Adolescent with anorexia nervosa: consequences on bone mineralization].

Nicaise D, Beaumesnil M, Chaillou E, Wagner AC, Avarello G, Audran M, Giniès JL.

Arch Pediatr. 2012 Jan;19(1):17-21. doi: 10.1016/j.arcped.2011.10.022. Epub 2011 Dec 1. French.

PMID:
22137016

Supplemental Content

Loading ...
Support Center